Episode 94

About this episode

Dr. Stader and Dr. Bradley discuss key insights on buprenorphine for pain and harm reduction strategies for benzodiazepine use.

In t his episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing buprenorphine for pain, harm reduction for benzodiazepine use , and more! Buprenorphine for the Management of Chronic Pain: National Guidance Document , Published by the VA Pharmacy Benefits Management Services and the National Formulary Committee in Collaboration with the VHA National Office of Pain Management, Opioid Safety and PDMP (PMOP), March 2024 Harm reduction approaches for the use of benzodiazepines: a scoping review , Published in Springer Nature Link, October 2025 Definitive urine drug test findings in patients prescribed opioids for pain from a large national database , Published in the Journal of Opioid Management, July-August 2022 Duration of Methadone and Buprenorphine-Naloxone Treatment , Published in JAMA Network Open, July 2025 Safe and Sufficient—Ibuprofen for Pediatric Musculoskeletal Injuries , Published in JAMA, January 2026

People in this episode

Host: Dr. Don Stader

Guest: Dr. Bradley

Topics covered

• buprenorphine for pain
• harm reduction
• benzodiazepine use
• opioid management
• chronic pain treatment

Keywords

• buprenorphine
• pain management
• harm reduction
• benzodiazepines
• opioid safety
• urine drug testing
• methadone treatment
• pediatric injuries

Mentioned in this episode

Organizations: VA Pharmacy Benefits Management Services, National Formulary Committee, VHA National Office of Pain Management, Journal of Opioid Management, JAMA Network Open, JAMA

More episodes of Compass Opioid Stewardship Coaches Top 5 Podcast

• Episode 99 · March 30, 2026 · 13 min
• Episode 98 · March 25, 2026 · 13 min
• Episode 97 · March 23, 2026 · 14 min
• Episode 96 · March 12, 2026 · 13 min
• Episode 95 · March 9, 2026 · 13 min
• Episode 93 · February 12, 2026 · 12 min